Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep ...

Researchers have found in a new research that SGLT2 inhibitors may provide dual benefits in treating both diabetes and fatty ...

Populations of African descent are at the forefront of the worldwide epidemic of type 2 diabetes mellitus (T2DM). Here, Anne Sumner and colleagues discuss issues related to the diagnosis and ...

Guidelines for pregnancy care in individuals with preexisting diabetes mellitus include stopping GLP-1 RA use and avoiding metformin.

T2DM: self-reported T2DM and received anti-diabetes medications, or based on clinical test (FBG ≥ 126 mg/dl or HbA1C ≥ 6.5%) Exposure: self-reported tooth loosening (N = 262) ...

Type 2 diabetes (T2DM) is a systematic multi-organ metabolic disease, which is characterized by dynamic interplay among different organs. Pancreatic islet-liver axis is closely associated with normal ...

Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). T2DM is a condition that occurs when the body develops insulin resistance and no longer responds effectively to insulin .

T2DM: self-reported T2DM and received anti-diabetes medications, or based on clinical test (FBG ≥ 126 mg/dl or HbA1C ≥ 6.5%) Exposure: self-reported tooth loosening (N = 262) ...